• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Novel host cell pathway hijacked during COVID-19 infection uncovered by Bristol researchers

Bioengineer by Bioengineer
June 14, 2022
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

An international team of scientists, led by the University of Bristol, has been investigating how the SARS-CoV-2 virus, the coronavirus responsible for the COVID-19 pandemic, manipulates host proteins to penetrate into human cells.  After identifying Neuropilin-1 (NRP1) as a host factor for SARS-CoV-2 infection, new findings published in the journal of the Proceedings of the National Academy of Sciences (PNAS) today [14 June] describe how the coronavirus subverts a host cell pathway in order to infect human cells.

Graphic image explaining how SARS-CoV-2 hijacks ESCPE-1

Credit: Second Bay Studios

An international team of scientists, led by the University of Bristol, has been investigating how the SARS-CoV-2 virus, the coronavirus responsible for the COVID-19 pandemic, manipulates host proteins to penetrate into human cells.  After identifying Neuropilin-1 (NRP1) as a host factor for SARS-CoV-2 infection, new findings published in the journal of the Proceedings of the National Academy of Sciences (PNAS) today [14 June] describe how the coronavirus subverts a host cell pathway in order to infect human cells.

SARS-CoV-2 continues to have a major impact on communities and industries around the world. In an attempt to find innovative strategies to block SARS-CoV-2 infection, the team previously identified NRP1 as an important receptor at the surface of cells that is hijacked by SARS-CoV-2 to enhance infection.

NRP1 is a dynamic receptor that senses the microscopic cellular environment through the recognition of proteins containing specific neuropilin-binding sequences, called ligands. By mimicking this neuropilin-binding sequence, SARS-CoV-2 is able to subvert this receptor to enhance its entry and infection of human cells.

In this new study, the group led by Bristol’s Faculty of Life Sciences, Professor Peter Cullen from the School of Biochemistry and Drs Boris Simonetti, Senior Researcher and James Daly, Research Associate, in the Cullen lab, has now identified NRP1 and its ligands are transported within the host cell by a protein complex, called ESCPE-1.  The protein complex captures NRP1 and regulates its transport between compartments inside the cell.

The function of this pathway is still not completely clear, but the team found that using gene editing to remove ESCPE-1 from human cells effectively blocked SARS-CoV-2 infection by around 50%, suggesting that this process is beneficially hijacked by the virus during the infection process.

Pete, Boris and James, explained: “This study represents an advance in the understanding of the pandemic coronavirus, and how it subverts host biology in order to infect cells. The identification of this pathway used by SARS-CoV-2 opens avenues for designing therapeutic interventions that can prevent ESCPE-1 and NRP1 from associating with the Spike protein to reduce infection.”

Paper

‘ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1’ by Boris Simonetti, James L. Daly, Pete J. Cullen et al in PNAS [open access]



Journal

Proceedings of the National Academy of Sciences

DOI

10.1073/pnas.2201980119

Method of Research

Observational study

Subject of Research

Cells

Article Title

‘ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1

Article Publication Date

14-Jun-2022

Share12Tweet7Share2ShareShareShare1

Related Posts

Scientists Reveal Link Between Gut Fungi, Human Genetics, and Disease Susceptibility

September 2, 2025

Combining Sterile Insects and Fungi to Combat Drosophila

September 2, 2025

Jaw by jaw: How biting shaped the evolution of fish

September 2, 2025

New Research Reveals Role of Exosomes in Biological Aging

September 2, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    154 shares
    Share 62 Tweet 39
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • Needlestick Injury Rates in Nurses and Students in Pakistan

    123 shares
    Share 49 Tweet 31
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Nurse Activity Levels Linked to Work Demographics

Global Trends and Disparities in Urinary Tumors (1990-2046)

Fluorine “Forever Chemical” in Medicines Does Not Increase Drug Reaction Risks

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.